Table 2.
Univariable analysis for overall survivals
| Univariate analysis | ||
|---|---|---|
| Hazard ratio (95% CI) | P values | |
| Age (> 70) | 1.80 (0.48–6.78) | 0.37 |
| Sex (male) | 4.82 (0.62–37.73) | 0.093 |
| Smoking history ( +) | 0.55 (0.15–1.96) | 0.34 |
| Comorbidities (any) | 3.93 (0.84–18.34) | 0.057 |
| Diabetes | 1.60 (0.42–6.07) | 0.48 |
| Hypertension | 2.15 (0.65–7.09) | 0.19 |
| Coronary heart disease | 1.41 (0.30–6.54) | 0.65 |
| Chronic obstructive lung disease | 1.64 (0.35–7.62) | 0.52 |
| Asthma | 1.64 (0.21–13.14) | 0.63 |
| Cancer type (hematologic malignancy) | 1.36 (0.36–5.13) | 0.64 |
| Cancer treatment (any treatment within ≤ 30 days) | 1.31 (0.40–4.33) | 0.65 |
| Cancer status (active cancer) | 1.16 (0.35–3.83) | 0.80 |
| Neutrophil count (< 1.5), × 109/L | 2.73 (0.59–12.67) | 0.18 |
| Lymphocyte count (< 0.8), × 109/L | 5.74 (1.50–21.92) | 0.004 |
| Albumin (< 3.0), g/L | 5.32 (1.47–19.21) | 0.004 |
| Lactate dehydrogenase (> 350), U/L | 4.40 (1.33–14.63) | 0.008 |
| Serum ferritin (> 800), μg/L | 6.12 (1.18–31.79) | 0.014 |
| C-reactive protein (> 5.0), mg/dL | 5.82 (1.53–22.09) | 0.010 |
| d-dimer (> 1.0), μg/L | 1.10 (0.27–4.38) | 0.90 |
CI confidential interval